Hungarian authorities review Sinopharm vaccine production in Beijing
Image by Africa Studio / Shutterstock.com
Experts of the National Institute of Pharmacy and Nutrition (OGYÉI) have reviewed production of the Sinopharm COVID-19 vaccine in Beijing, department head Ferenc Lukács told state news wire MTI by phone.
Lukács said the experts had conducted a Good Manufacturing Practice (GMP) inspection of the facility where the vaccine is made, reviewing the entire production line and obtaining the full documentation on production processes.
"Everything we wanted to see, we got to see," he added.
He noted that the vaccine can be stored at a temperature of between 2 and 8 degrees Celsius, making safe delivery "easy to ensure".
Gergely Gulyás, who heads the Prime Minister's Office, said at a press briefing on Thursday that Hungary had "practically reached an agreement" on the delivery of the Sinopharm vaccine. He added that the first shipment could be as large as 1 million doses, pending approval by Hungarian medicines authorities.
Rail Cargo Group Leases Logisztár Terminal to S. Korean Logi...
Liz & Chain Rooftop Bar Debuts Sustainable Cocktails
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
